MYELODYSPLASTIC SYNDROME ASSOCIATED WITH BONE-MARROW FIBROSIS

被引:25
|
作者
LAMBERTENGHIDELILIERS, G
ANNALORO, C
ORIANI, A
SOLIGO, D
机构
[1] Istituto di Scienze Mediche, University of Milan, Fondazione Matarelli, Milan
关键词
MYELODYSPLASTIC SYNDROME; BONE MARROW FIBROSIS;
D O I
10.3109/10428199209049817
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone marrow biopsy (BMB) in myelodysplastic syndrome (MDS) frequently reveals a slight alteration in the reticulin stroma which does not have any clinical significance. However, in a minority of cases, full-blown bone marrow fibrosis (BMF) can be found. Primary MDS patients with BMF show distinct clinico-pathological features and an unfavourable prognosis mainly attributable to complications deriving from pancytopenia and continuous transfusions, while leukemic transformation occurs only rarely. Since BMF may characterize other hematological disorders, primary MDS with BMF should be included in the differential diagnosis particularly with malignant myelofibrosis (MM) and idiopathic myelofibrosis (IMF). Secondary MDS with BMF represent a variety of preleukemic conditions in subjects treated for previous neoplasias. Unlike the primary forms, they do not form a clearcut clinico-pathological entity.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 50 条
  • [41] A LACK OF HEMATOPOIETIC SUPPORTIVE FUNCTION OF BONE-MARROW STROMAL CELLS IN THE PATIENTS WITH MYELODYSPLASTIC SYNDROME
    AIZAWA, S
    IWASE, O
    YAGUCHI, M
    KURIYAMA, Y
    TOYAMA, K
    TOHYAMA, K
    NAKAMURA, T
    KAIDOH, A
    HANDA, H
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 903 - 903
  • [42] FUNCTIONAL-STUDIES OF BONE-MARROW HEMATOPOIETIC AND STROMAL CELLS IN THE MYELODYSPLASTIC SYNDROME (MDS)
    COUTINHO, LH
    GEARY, CG
    CHANG, J
    HARRISON, C
    TESTA, NG
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) : 16 - 25
  • [43] ADENOVIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME IN A BONE-MARROW TRANSPLANT PATIENT
    WODELL, R
    GUPTA, R
    BAYEVER, E
    AUGUST, C
    PLOTKIN, S
    PEDIATRIC RESEARCH, 1985, 19 (04) : A269 - A269
  • [44] INTENSIVE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES
    LOFFLER, H
    SCHMITZ, N
    GASSMANN, W
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (03) : 619 - 631
  • [45] BONE-MARROW CULTURES AND PROGNOSIS IN PRIMARY MYELODYSPLASTIC SYNDROMES
    KORTHOUT, M
    DEBOCK, R
    VANBOCKSTAELE, D
    PEETERMANS, M
    LEUKEMIA RESEARCH, 1990, 14 (01) : 85 - 89
  • [46] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    ARNOLD, R
    HEIMPEL, H
    BONE MARROW TRANSPLANTATION, 1989, 4 : 101 - 103
  • [47] BONE-MARROW KARYOTYPE AND PROGNOSIS IN PRIMARY MYELODYSPLASTIC SYNDROMES
    BILLSTROM, R
    THIEDE, T
    HANSEN, S
    HEIM, S
    KRISTOFFERSSON, U
    MANDAHL, N
    MITELMAN, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 41 (04) : 341 - 346
  • [48] IMMUNOHISTOCHEMICAL EVALUATION OF BONE-MARROW BIOPSIES IN MYELODYSPLASTIC SYNDROMES
    SOLIGO, D
    LUKSCH, R
    QUIRICI, N
    FOA, P
    MONETA, D
    SOMALVICO, F
    DELILIERS, GL
    HAEMATOLOGIA, 1991, 24 (01) : 39 - 46
  • [49] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    UBERTI, JP
    RATANATHARATHORN, V
    KARANES, C
    SENSENBRENNER, LL
    LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) : 379 - 385
  • [50] A case of myelodysplastic syndrome with bone marrow fibrosis and isochromosomy of 17(q10)
    Valizadeh, Nasim
    Yaghmaie, Marjan
    CLINICAL CANCER INVESTIGATION JOURNAL, 2018, 7 (03): : 110 - 112